• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    (NY: ENOV )

    43.03 +0.60 (+1.41%)
    Official Closing Price Updated: 7:00 PM EST, Nov 4, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Headline News about ENOV

    < Previous 1 2 Next >
    Orthopedic Implant Player Enovis' M&A Strategy Core To Growth And Competitiveness, Analyst Says
    JMP Securities initiates coverage on Enovis Corporation with a Market Outperform rating, highlighting its strategic acquisitions, including LimaCorporate, and future growth potential. The analyst notes... 
    Via Benzinga
    The Latest Analyst Ratings For Enovis
    Via Benzinga
    ENOV Stock Earnings: Enovis Beats EPS, Misses Revenue for Q2 2024
    ENOV stock results show that Enovis beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024. 
    Via InvestorPlace
    Critical Insights From Enovis Analyst Ratings: What You Need To Know
    Via Benzinga
    Top 3 Health Care Stocks That Could Blast Off In June
    Via Benzinga
    5 Medical Info Systems Stocks To Buy For Stable Returns
    The medical info systems industry is thriving due to the growing demand for contactless services. Amid this environment, here are some stocks in the industry that may see stable returns in 2024. 
    Via Talk Markets
    A Closer Look at 6 Analyst Recommendations For Enovis
    Via Benzinga
    Earnings Outlook For Enovis
    Via Benzinga
    5 Analysts Have This To Say About Enovis
    Via Benzinga
    The Analyst Landscape: 6 Takes On Enovis
    Via Benzinga
    Top 4 Health Care Stocks Which Could Rescue Your Portfolio This Month
    Via Benzinga
    ENOV Stock Earnings: Enovis Beats EPS, Beats Revenue for Q1 2024
    ENOV stock results show that Enovis beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
    Via InvestorPlace
    Medtech Firm Enovis Sets Strong 2024 Targets As Q4 Earnings Beat Expectations, Analyst Says Growth Intact
    Enovis reports Q4 results with net sales surging 11% YoY, reaching $455 million. The growth is attributed to strong performance in P&R and above-market expansion in Recon, coupled with recent... 
    Via Benzinga
    Topics Earnings
    Exposures Financial
    This Analyst Sees Durable Share Gains, Margin Expansion For Orthopedics-Focused Enovis
    William Bliar has initiated coverage on Enovis Corp (NYSE: ENOV), a medical technology company focusing on the orthopedics market valued at approximately $25 billion, experiencing steady growth,... 
    Via Benzinga
    This Analyst Selects Enovis As Top Pick For 2024: Spotlight On EMPOWR Revision Launch
    Needham analyst Mike Matson reiterated the Buy rating on Enovis Corporation (NYSE: ENOV), raising  
    Via Benzinga
    Analyst Ratings for Enovis
    Via Benzinga
    4 Analysts Have This to Say About Enovis
    Via Benzinga
    Looking Into Enovis's Return On Invested Capital
    Via Benzinga
    Enovis Beats Q1 Earnings Estimates, Raises 2023 Guidance
      
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For October 20, 2023
    Via Benzinga
    Why Enovis Stock Is Trading Lower Today
    Enovis Corporation (NYSE: ENOV) shares are trading lower on Thursday after the company announced a proposed private offering of $400 million of convertible senior notes and issued 
    Via Benzinga
    Big Moves In Orthopedics: Enovis Seals €800M Deal To Acquire LimaCorporate
    Enovis Corp (NYSE: ENOV) inked a deal to acquire LimaCorporate S.p.A. for an 
    Via Benzinga
    Enovis Above-Market Growth Potential Surge Would Come from Market Share Gains and Accretive Acquisitions: Analyst
    Needham initiated coverage on Enovis Corp (NYSE: ENOV) with a Buy and a price target of $70, noting that the company can sustain above-market growth in its Reconstructive segment via market share gains... 
    Via Benzinga
    Enovis: Q1 Earnings Insights
    Via Benzinga
    Earnings Outlook For Enovis
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For June 26, 2023
    Via Benzinga
    3 Dividend Stocks That Are Raising Their Payouts
    Earnings have been remarkably resilient despite higher prices. Here are three dividend stocks that are increasing payouts as a result. 
    Via InvestorPlace
    Benzinga's Top Ratings Upgrades, Downgrades For May 12, 2023
    Via Benzinga
    Hyatt Hotels To Rally Over 26%? Here Are 10 Other Analyst Forecasts For Friday
    Wells Fargo raised the price target for Enovis Corporation (NYSE: ENOV) from $55 to $67. Wells Fargo analyst Vik Chopra upgraded the stock from Equal-Weight to Overweight. Enovis shares rose 1.9% to... 
    Via Benzinga
    This Analyst With 83% Accuracy Rate Sees Around 11% Upside In Texas Roadhouse - Here Are 5 Stock Picks For Last Week From Wall Street's Most Accurate Analysts
    U.S stocks closed higher on Friday, with the Dow Jones jumping more than 500 points during the session. 
    Via Benzinga
    < Previous 1 2 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.